The FDA inspection on its Tarapur facility, conducted earlier this year, has been concluded as “closed,” with the inspection classification designated as “voluntary action indicated” (VAI).
The FDA inspection on its Tarapur facility, conducted earlier this year, has been concluded as “closed,” with the inspection classification designated as “voluntary action indicated” (VAI).